Radioimnnunotherapy prevents local recurrence of colonic cancer in an experimental model

British Journal of Surgery

Volumn 96, Issue 3, 2009, Pages 314-321

  De Jong, G M ^a,c   Boerman, O C ^b   Heskamp, S ^b   Aarts, F ^a   Bleiehrodt, R P ^a   Hendriks, T ^a  

^a Division of Oncology and Abdominal Surgery   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MG1 IN 111; MONOCLONAL ANTIBODY MG1 LU 177; UNCLASSIFIED DRUG; LUTETIUM; PENTETIC ACID; RADIOISOTOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; COLON CANCER; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RAT; TUMOR GROWTH; ANIMAL; BODY WEIGHT; CANCER TRANSPLANTATION; COLON TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR RECURRENCE; TUMOR VOLUME;

ANIMALS; ANTIBODIES, MONOCLONAL; BODY WEIGHT; CELL LINE, TUMOR; COLONIC NEOPLASMS; LUTETIUM; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; PENTETIC ACID; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RATS; TUMOR BURDEN;

EID: 61749091233     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6481     Document Type: Article

References (41)

1. National Cancer Institute. http://www.cancer.gov/[accessed 13 June 2007].
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
3. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-543.
4. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 1994; 81: 7-19.
5. Sjövall A, Granath F, Cedermark B, Glimelius B, Holm T. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol 2007; 14: 432-440.
6. Read TE, Mutch MG," Chang BW, McNevin MS, Fleshman JW, Birnbaum EH et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 2002; 195: 33-40.
7. Enker WE, Laffer UT, Block GE. Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection. Ann Surg 1979; 190: 350-360.
8. Obrand DI, Gordon PH. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 1997; 40: 15-24.
9. Dorrance HR, Docherty GM, O'Dwyer PJ. Effect of surgeon specialty interest on patient outcome after potentially curative colorectal cancer surgery. Dis Colon Rectum 2000; 43: 492-498.
10. Burdy G, Panis Y, Alves A, Nemeth J, Lavergne-Slove A, Valleur P. Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence. Dis Colon Rectum 2001; 4: 1682-1688.
11. Safioleas MC, Moulakakis KG, Stamatakos M, Kountouras J, Lygidakis NJ. Local recurrence following curative low anterior resection for rectal carcinoma. Hepatogastroenterology 2005; 52: 94-96.
12. Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 2004; 47: 1599-1606.
13. Martling A, Singnomklao T, Holm T, Rutqvist LE, Cedermark B. Prognostic significance of both surgical and pathological assessment of curative resection for rectal cancer. Br J Surg 2004; 91: 1040-1045.
14. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 2006; 93: 1115-1122.
15. van den Tol PM, van Rossen EE, van Eijck CH, Bonthuis F, Marquet RL, Jeekel H. Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann Surg 1998; 227: 242-248.
16. Crowther M, Brown NJ, Bishop ET, Lewis CE. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 2001; 70: 478-490.
17. van Rossen ME, Hofland LJ, van den Tol MP, van Koetsveld PM, Jeekel J, Marquet RL et al. Effect of inflammatory cytokines and growth factors on tumour cell adhesion to the peritoneum. J Pathol 2001; 193: 530-537.
18. Oosterling SJ, van der Bij GJ, van Egmond M, van der Sijp JR. Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur J Surg Oncol 2005; 31: 29-37.
19. Behr TM, Salib AL, Liersch T, Béhé M, Angerstein C, Blumenthal RD et al. Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study. Clin Cancer Res 1999; 5(Suppl): 3232s-3242s.
20. Blumenthal RD, Sharkey RM, Natale AM, Kashi R, Wong G, Goldenberg DM. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts. Cancer Res 1994; 54: 142-151.
21. Koppe MJ, Soede AC, Pels W, Oyen WJ, Goldenberg DM, Bleichrodt RP et al. Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin. Int J Cancer 2003; 106: 965-972.
22. Aarts F, Hendriks T, Boerman OC, Koppe MJ, Oyen WJ, Bleichrodt RP. A comparison between radioimmunotherapy and hypertherrnic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. Ann Surg Oncol 2007; 14: 3274-3282.
23. Behr TM, Goldenberg DM, Becker WS. Radioimmunotherapy of solid tumors: a review 'of mice and men'. Hybridoma 1997; 16: 101-107.
24. Koppe MJ, Postema EJ, Aarts F, Oyen WJ, Bleichrodt RP, Boerman OC. Antibody-guided radiation therapy of cancer. Cancer Metastasis Rev 2005; 24: 539-567.
25. Hagenaars M, Koelemij R, Ensink NG, van Eendenburg JD, van Vlierberghe RL, Eggermont AM et al. The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma. Clin Exp Metastasis 2000; 18: 281-289.
26. Zedeck MS, Sternberg SS. A model system for studies of colon carcinogenesis: tumor induction by a single injection of methylazoxymethanol acetate. J Natl Cancer Inst 1974; 53: 1419-1421.
27. Koppe MJ, Hendriks T, Boerman OC, Oyen WJ, Bleichrodt RP. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis. J Nucl Med 2006; 47: 1867-1874.
28. Hagenaars M, Ensink NG, Basse PH, Hokland M, Nannmark U, Eggermont AM et al. The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for irnmunotherapy? Clin Exp Metastasis 2000; 18: 189-196.
29. Aarts F, Bleichrodt RP, de Man B, Lomme R, Boerman OC, Hendriks T. The effects of adjuvant experimental radioimmunotherapy and hypertherrnic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat. Ann Surg Oncol 2008; 15: 3299-3307.
30. Lopes Cardozo AM, Gupta A, Koppe MJ, Meijer S, van Leeuwen PA, Beelen RJ et al. Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: an experimental model of peritoneal carcinomatosis in rats. Eur J Surg Oncol 2001; 27: 359-363.
31. Lauwers P, Hubens G, Hendriks J, Vermeulen P, Schuerwegh A, Stevens WJ et al. Effects of suramin on anastomotic colon tumors in a rat model. Eur Surg Res 1999; 31:347-356.
32. Kluger Y, Galili Y, Yossiphov J, Shnaper A, Goldman G, Rabau M. Model of implantation of tumor cells simulating recurrence in colonic anastomosis in mice. Dis Colon Rectum 1998; 41: 1506-1510.
33. The Dutch Association of Comprehensive Cancer Centres. http://www.oncoline.nl/[accessed 18 July 2007].
34. Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985; 98:414-422.
35. Kelsen DP, Saltz L, Cohen AM, Yao TJ, Enker W, Tong W et al. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Cancer 1994; 74: 2224-2233.
36. Archer S, Gray B. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver rnicrometastases. Surgery 1990; 108: 502-507.
37. Umpleby HC, Williamson RC. The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma. Ann R Coll Surg Engl 1984; 66: 192-194.
38. Docherty JG, McGregor JR, Purdie CA, Galloway DJ, O'Dwyer PJ. Efficacy of tumoricidal agents in vitro and in vivo. Br J Surg 1995; 82: 1050-1052.
39. Basha G, Penninckx F, Yap P. Influence of blood components and faeces on the in vitro cancericidal activity of povidone-iodine. Br J Surg 1998; 85: 534-537.
40. Basha G, Ghirardi M, Geboes K, Yap SH, Penninckx F. Limitations of peritoneal lavage with antiseptics in prevention of recurrent colorectal cancer caused by tumor-cell seeding: experimental study in rats. Dis Colon Rectum 2000; 43: 1713-1718.
41. Huguet EL, Keeling NJ. Distilled water peritoneal lavage after colorectal cancer surgery. Dis Colon Rectum 2004; 47: 2114-2119.